Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 39 articles:
HTML format
Text format



Single Articles


    March 2017
  1. BOUILLEZ A, Rajabi H, Jin C, Samur M, et al
    MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer.
    Oncogene. 2017 Mar 13. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    February 2017
  2. SHI ZM, Wang L, Shen H, Jiang CF, et al
    Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling.
    Oncogene. 2017 Feb 13. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    January 2017
  3. HSIEH CH, Chou YT, Kuo MH, Tsai HP, et al
    A targetable HB-EGF-CITED4 axis controls oncogenesis in lung cancer.
    Oncogene. 2017 Jan 16. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    November 2016
  4. ENDO H, Okami J, Okuyama H, Nishizawa Y, et al
    The induction of MIG6 under hypoxic conditions is critical for dormancy in primary cultured lung cancer cells with activating EGFR mutations.
    Oncogene. 2016 Nov 28. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  5. SHI L, Wang Y, Lu Z, Zhang H, et al
    miR-127 promotes EMT and stem-like traits in lung cancer through a feed-forward regulatory loop.
    Oncogene. 2016 Nov 21. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  6. GUO JY, Hsu HS, Tyan SW, Li FY, et al
    Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner.
    Oncogene. 2016 Nov 7. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    October 2016
  7. CHEN F, Zhang Y, Parra E, Rodriguez J, et al
    Multiplatform-based molecular subtypes of non-small-cell lung cancer.
    Oncogene. 2016 Oct 24. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  8. WANG D, Shi W, Tang Y, Liu Y, et al
    Prefoldin 1 promotes EMT and lung cancer progression by suppressing cyclin A expression.
    Oncogene. 2016 Oct 3. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  9. PENG DH, Ungewiss C, Tong P, Byers LA, et al
    ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis.
    Oncogene. 2016 Oct 3. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    August 2016
  10. ZELENKO Z, Gallagher EJ, Tobin-Hess A, Belardi V, et al
    Silencing vimentin expression decreases pulmonary metastases in a pre-diabetic mouse model of mammary tumor progression.
    Oncogene. 2016 Aug 29. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  11. KAO YC, Jheng JR, Pan HJ, Liao WY, et al
    Elevated hydrostatic pressure enhances the motility and enlarges the size of the lung cancer cells through aquaporin upregulation mediated by caveolin-1 and ERK1/2 signaling.
    Oncogene. 2016 Aug 8. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    June 2016
  12. CHIU LY, Hsin IL, Yang TY, Sung WW, et al
    The ERK-ZEB1 pathway mediates epithelial-mesenchymal transition in pemetrexed resistant lung cancer cells with suppression by vinca alkaloids.
    Oncogene. 2016 Jun 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    May 2016
  13. MA Y, Yu C, Mohamed EM, Shao H, et al
    A causal link from ALK to hexokinase II overexpression and hyperactive glycolysis in EML4-ALK-positive lung cancer.
    Oncogene. 2016 May 2. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    April 2016
  14. DODD RD, Sachdeva M, Mito JK, Eward WC, et al
    Myogenic transcription factors regulate pro-metastatic miR-182.
    Oncogene. 2016;35:1868-75.
    PubMed     Text format     Abstract available


    January 2016
  15. LAKSHMANAN I, Rachagani S, Hauke R, Krishn SR, et al
    MUC5AC interactions with integrin beta4 enhances the migration of lung cancer cells through FAK signaling.
    Oncogene. 2016 Jan 11. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    November 2015
  16. WANG YC, Wang SA, Chen PH, Hsu TI, et al
    Variants of ubiquitin-specific peptidase 24 play a crucial role in lung cancer malignancy.
    Oncogene. 2015 Nov 16. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  17. MALIN D, Strekalova E, Petrovic V, Rajanala H, et al
    ERK-regulated alphaB-crystallin induction by matrix detachment inhibits anoikis and promotes lung metastasis in vivo.
    Oncogene. 2015;34:5626-34.
    PubMed     Text format     Abstract available


    October 2015
  18. BIKKAVILLI RK, Avasarala S, Van Scoyk M, Arcaroli J, et al
    Wnt7a is a novel inducer of beta-catenin-independent tumor-suppressive cellular senescence in lung cancer.
    Oncogene. 2015;34:5406.
    PubMed     Text format    


  19. KAUR J, Tikoo K
    Ets1 identified as a novel molecular target of RNA aptamer selected against metastatic cells for targeted delivery of nano-formulation.
    Oncogene. 2015;34:5216-28.
    PubMed     Text format     Abstract available


    September 2015
  20. LUANPITPONG S, Li J, Manke A, Brundage K, et al
    SLUG is required for SOX9 stabilization and functions to promote cancer stem cells and metastasis in human lung carcinoma.
    Oncogene. 2015 Sep 21. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    August 2015
  21. JEN J, Lin LL, Chen HT, Liao SY, et al
    Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer.
    Oncogene. 2015 Aug 17. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  22. HASEGAWA Y, Takahashi M, Ariki S, Asakawa D, et al
    Surfactant protein D suppresses lung cancer progression by downregulation of epidermal growth factor signalling.
    Oncogene. 2015;34:4285-6.
    PubMed     Text format    


    July 2015
  23. WU YC, Tang SJ, Sun GH, Sun KH, et al
    CXCR7 mediates TGFbeta1-promoted EMT and tumor-initiating features in lung cancer.
    Oncogene. 2015 Jul 27. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  24. JIANG L, Xiao L, Sugiura H, Huang X, et al
    Metabolic reprogramming during TGFbeta1-induced epithelial-to-mesenchymal transition.
    Oncogene. 2015;34:3908-16.
    PubMed     Text format     Abstract available


  25. MERINO D, Best SA, Asselin-Labat ML, Vaillant F, et al
    Pro-apoptotic Bim suppresses breast tumor cell metastasis and is a target gene of SNAI2.
    Oncogene. 2015;34:3926-34.
    PubMed     Text format     Abstract available


  26. NAVAB R, Strumpf D, To C, Pasko E, et al
    Integrin alpha11beta1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer.
    Oncogene. 2015 Jul 6. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  27. WU DW, Lee MC, Hsu NY, Wu TC, et al
    FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-kappaB/Slug-mediated PUMA reduction.
    Oncogene. 2015;34:3882-3.
    PubMed     Text format    


  28. CUI H, Seubert B, Stahl E, Dietz H, et al
    Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes.
    Oncogene. 2015;34:3640-50.
    PubMed     Text format     Abstract available


  29. TRUESDELL P, Ahn J, Chander H, Meens J, et al
    CIP4 promotes lung adenocarcinoma metastasis and is associated with poor prognosis.
    Oncogene. 2015;34:3527-35.
    PubMed     Text format     Abstract available


    June 2015
  30. WHANG YM, Park SI, Trenary IA, Egnatchik RA, et al
    LKB1 deficiency enhances sensitivity to energetic stress induced by erlotinib treatment in non-small-cell lung cancer (NSCLC) cells.
    Oncogene. 2015 Jun 29. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  31. LATINA A, Viticchie G, Lena AM, Piro MC, et al
    DeltaNp63 targets cytoglobin to inhibit oxidative stress-induced apoptosis in keratinocytes and lung cancer.
    Oncogene. 2015 Jun 22. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  32. CASTILLO-LLUVA S, Hontecillas-Prieto L, Blanco-Gomez A, Del Mar Saez-Freire M, et al
    A new role of SNAI2 in postlactational involution of the mammary gland links it to luminal breast cancer development.
    Oncogene. 2015 Jun 22. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  33. KURPPA KJ, Denessiouk K, Johnson MS, Elenius K, et al
    Activating ERBB4 mutations in non-small cell lung cancer.
    Oncogene. 2015 Jun 8. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  34. KURIYAMA S, Yoshida M, Yano S, Aiba N, et al
    LPP inhibits collective cell migration during lung cancer dissemination.
    Oncogene. 2015 Jun 1. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    May 2015
  35. PAN D, Jiang C, Ma Z, Blonska M, et al
    MALT1 is required for EGFR-induced NF-kappaB activation and contributes to EGFR-driven lung cancer progression.
    Oncogene. 2015 May 18. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  36. WANG L, Yang H, Lei Z, Zhao J, et al
    Repression of TIF1gamma by SOX2 promotes TGF-beta-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
    Oncogene. 2015 May 11. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  37. YONESAKA K, Hirotani K, Kawakami H, Takeda M, et al
    Anti-HER3 monoclonal antibody patritumab sensitizes refractory non-small cell lung cancer to the epidermal growth factor receptor inhibitor erlotinib.
    Oncogene. 2015 May 11. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    January 2015
  38. FAN LC, Shiau CW, Tai WT, Hung MH, et al
    SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma.
    Oncogene. 2015 Jan 26. doi: 10.1038/onc.2014.
    PubMed     Text format     Abstract available


    September 2014
  39. MO P, Zhou Q, Guan L, Wang Y, et al
    Amplified in breast cancer 1 promotes colorectal cancer progression through enhancing notch signaling.
    Oncogene. 2014 Sep 29. doi: 10.1038/onc.2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: